Literature DB >> 17984168

Illuminating HDL--is it still a viable therapeutic target?

Daniel J Rader.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17984168     DOI： 10.1056/NEJMe0707210

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  42 in total

1.  Evaluation of benefit-risk.

Authors:  Silvio Garattini
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  [Therapeutic drug option for dyslipaemia].

Authors:  Antonio Maiques Galan; Carlos Brotons Cuixart
Journal:  Aten Primaria       Date:  2009-06-04       Impact factor: 1.137

Review 3.  Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches.

Authors:  Emil M deGoma; Rolando L deGoma; Daniel J Rader
Journal:  J Am Coll Cardiol       Date:  2008-06-10       Impact factor: 24.094

4.  Low-density lipoprotein cholesterol reduction and prevention of cardiovascular disease.

Authors:  Evan A Stein
Journal:  Mayo Clin Proc       Date:  2009-04       Impact factor: 7.616

5.  Future of cholesteryl ester transfer protein (CETP) inhibitors: a pharmacological perspective.

Authors:  Amir Hooshang Mohammadpour; Fatemeh Akhlaghi
Journal:  Clin Pharmacokinet       Date:  2013-08       Impact factor: 6.447

Review 6.  Novel HDL-directed pharmacotherapeutic strategies.

Authors:  Emil M Degoma; Daniel J Rader
Journal:  Nat Rev Cardiol       Date:  2011-01-18       Impact factor: 32.419

7.  Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib.

Authors:  Laurent Yvan-Charvet; Jelena Kling; Tamara Pagler; Hongna Li; Brian Hubbard; Tim Fisher; Carl P Sparrow; Andrew K Taggart; Alan R Tall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-05-06       Impact factor: 8.311

Review 8.  Common sense treatment for common lipid disorders.

Authors:  Mariko Johnson; Clay F Semenkovich
Journal:  Mo Med       Date:  2011 Mar-Apr

Review 9.  Novel concepts in HDL pharmacology.

Authors:  Alan T Remaley; Giuseppe D Norata; Alberico L Catapano
Journal:  Cardiovasc Res       Date:  2014-06-20       Impact factor: 10.787

Review 10.  Low high-density lipoprotein cholesterol: current status and future strategies for management.

Authors:  Vibhuti Singh; Rakesh Sharma; Ajoy Kumar; Prakash Deedwania
Journal:  Vasc Health Risk Manag       Date:  2010-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.